In the Original Investigation titled “Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19”1 that printed on January 4, 2021, the nonauthor collaborator names were omitted from the PubMed listing. The article has been corrected by adding Supplement 3 containing all names.
Reference
- 1.Gupta S, Wang W, Hayek SS, et al. ; STOP-COVID Investigators . Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern Med. 2021;181(1):41-51. doi: 10.1001/jamainternmed.2020.6252 [DOI] [PMC free article] [PubMed] [Google Scholar]